ArticleJMIR formative research2025
A "Papageno" Story Interview Suicide Prevention Intervention for Young Adults With Past-Month Suicidal Ideation: Uncontrolled Single-Group Pilot Study of Feedback and Acceptability.
Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From surviving to thriving: a process-ecological model of psychological resilience in doctoral students.Frontiers in psychology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundSuicide continues to be a leading cause of death for young people, and the 2024 US National Strategy for Suicide Prevention has called for innovative approaches to suicide prevention. This strategy acknowledges the potential of the "Papageno" effect or the suicide preventive effect of stories of people who overcome suicide crises.
objectiveThis pilot study's objectives were to develop filmed interviews of young adults sharing their personal story of overcoming suicide crises ("Papageno" stories) and to examine their acceptability and appropriateness in a sample of young adults with a past-month history of suicidal ideation.
methodsIn total, 6 filmed interviews (5 "Papageno" story interviews and 1 active control interview) were videotaped. Study participants were recruited from Instagram and community organizations. Interviewees and participants were between the ages of 18 and 24 years. To be eligible for the study, participants responded "yes" to the question, "In the past 1 month, have you wished you were dead or wished you could go to sleep and not wake up?" Participants provided demographic information and responded to a Brief Mood Introspection Scale. They were subsequently instructed to watch the video, which was followed by the Brief Mood Introspection Scale and questions about the acceptability and helpfulness of the video. They were also asked 5 free-response questions regarding their likes, dislikes, suggestions, and overall reactions to the filmed interviews and whether they would watch it again.
resultsWe collected 3-4 participant responses per video for each of the 5 different interview videos (a total of 16 responses). The videos were found to be generally acceptable and appropriate, and no participants reported feeling less likely to reach out for help when needed. Qualitative feedback yielded recommendations to shorten the length of the videos as well as to include multiple interviewees in future videos so that the audience has a better chance to identify with the interviewee.
conclusionsFilmed "Papageno" interviews were rated as generally acceptable and appropriate, reinforcing the need for more research examining their potential effects on proximal risk factors for suicide. Next steps include the incorporation of feedback to create a singular finalized video and a randomized controlled trial assessing the effects of the Papageno video.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.